With Gilead’s CEO on the way out and revenues tumbling, the company needs a leader who can pump up cancer sales. And it may have found just that in the ranks of the world’s biggest cancer drug maker.
Your email address will not be published. Required fields are marked *
Monday, Tuesday, Wednesday, Thursday: what comes next? *
Leave a Comment